{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,24]],"date-time":"2024-09-24T04:05:35Z","timestamp":1727150735527},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,9,23]]},"DOI":"10.7759\/cureus.69999","type":"journal-article","created":{"date-parts":[[2024,9,23]],"date-time":"2024-09-23T14:40:19Z","timestamp":1727102419000},"source":"Crossref","is-referenced-by-count":0,"title":["Multiple Stress Fractures in a Young Cancer Patient on Long-Term Zoledronic Acid: A Case Report and Review of Literature"],"prefix":"10.7759","author":[{"given":"Jiayi","family":"Weng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ernest Beng Kee","family":"Kwek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.injury.2007.08.036","article-title":"An emerging pattern of subtrochanteric stress fractures: a long-term complication of alendronate therapy?","volume":"39","author":"Kwek EB","year":"2008","unstructured":"Kwek EB, Goh SK, Koh JS, Png MA, Howe TS. An emerging pattern of subtrochanteric stress fractures: a long-term complication of alendronate therapy?. Injury. 2008, 39:224-31. 10.1016\/j.injury.2007.08.036","journal-title":"Injury"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-008-0805-x","article-title":"Association of low-energy femoral fractures with prolonged bisphosphonate use: a case control study","volume":"20","author":"Lenart BA","year":"2009","unstructured":"Lenart BA, Neviaser AS, Lyman S, et al.. Association of low-energy femoral fractures with prolonged bisphosphonate use: a case control study. Osteoporos Int. 2009, 20:1353-62. 10.1007\/s00198-008-0805-x","journal-title":"Osteoporos Int"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2009.03581.x","article-title":"Unusual mid-shaft fractures during long-term bisphosphonate therapy","volume":"72","author":"Odvina CV","year":"2010","unstructured":"Odvina CV, Levy S, Rao S, Zerwekh JE, Rao DS. Unusual mid-shaft fractures during long-term bisphosphonate therapy. Clin Endocrinol (Oxf). 2010, 72:161-8. 10.1111\/j.1365-2265.2009.03581.x","journal-title":"Clin Endocrinol (Oxf)"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.47102\/annals-acadmedsg.V46N9p351","article-title":"A case of bilateral atypical ulnar fractures with bisphosphonate therapy in a walking aided elderly","volume":"46","author":"Yam MG","year":"2017","unstructured":"Yam MG, Kwek EB. A case of bilateral atypical ulnar fractures with bisphosphonate therapy in a walking aided elderly. Ann Acad Med Singapore. 2017, 46:351-3. 10.47102\/annals-acadmedsg.V46N9p351","journal-title":"Ann Acad Med Singapore"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2012.05.010","article-title":"Atypical femur fractures among breast cancer and multiple myeloma patients receiving intravenous bisphosphonate therapy","volume":"51","author":"Chang ST","year":"2012","unstructured":"Chang ST, Tenforde AS, Grimsrud CD, et al.. Atypical femur fractures among breast cancer and multiple myeloma patients receiving intravenous bisphosphonate therapy. Bone. 2012, 51:524-7. 10.1016\/j.bone.2012.05.010","journal-title":"Bone"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.4048\/jbc.2012.15.2.261","article-title":"Atypical subtrochanteric femur fracture in patient with metastatic breast cancer treated with zoledronic acid","volume":"15","author":"Kim YS","year":"2012","unstructured":"Kim YS, Park WC. Atypical subtrochanteric femur fracture in patient with metastatic breast cancer treated with zoledronic acid. J Breast Cancer. 2012, 15:261-4. 10.4048\/jbc.2012.15.2.261","journal-title":"J Breast Cancer"},{"key":"ref7","article-title":"Subtrochanteric fracture in a patient receiving zoledronic acid therapy for metastatic breast cancer","volume":"73","author":"Kishimoto Y","year":"2011","unstructured":"Kishimoto Y, Iwase T, Koyama A, Masui T, Yoshida G, Matsuo H, Ishiguro N. Subtrochanteric fracture in a patient receiving zoledronic acid therapy for metastatic breast cancer. Nagoya J Med Sci. 2011, 73:211-5.","journal-title":"Nagoya J Med Sci"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbo.2023.100478","article-title":"Multicenter study on atypical femoral fractures in patients with bone metastases taking bone- modifying agents","volume":"40","author":"Fukui T","year":"2023","unstructured":"Fukui T, Oe K, Kawamoto T, et al.. Multicenter study on atypical femoral fractures in patients with bone metastases taking bone- modifying agents. J Bone Oncol. 2023, 40:100478. 10.1016\/j.jbo.2023.100478","journal-title":"J Bone Oncol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.1998","article-title":"Atypical subtrochanteric and diaphyseal femoral fractures: second report of a task force of the American Society for Bone and Mineral Research","volume":"29","author":"Shane E","year":"2014","unstructured":"Shane E, Burr D, Abrahamsen B, et al.. Atypical subtrochanteric and diaphyseal femoral fractures: second report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res. 2014, 29:1-23. 10.1002\/jbmr.1998","journal-title":"J Bone Miner Res"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.08.017","article-title":"American Society of Clinical Oncology 2003 update on the role of bisphosphonates and bone health issues in women with breast cancer","volume":"21","author":"Hillner BE","year":"2003","unstructured":"Hillner BE, Ingle JN, Chlebowski RT, et al.. American Society of Clinical Oncology 2003 update on the role of bisphosphonates and bone health issues in women with breast cancer. J Clin Oncol. 2003, 21:4042-57. 10.1200\/JCO.2003.08.017","journal-title":"J Clin Oncol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa067312","article-title":"Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis","volume":"356","author":"Black DM","year":"2007","unstructured":"Black DM, Delmas PD, Eastell R, et al.. Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis. N Engl J Med. 2007, 356:1809-22. 10.1056\/NEJMoa067312","journal-title":"N Engl J Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2012-0261","article-title":"Adjuvant therapy with zoledronic acid in patients with breast cancer: a systematic review and meta-analysis","volume":"18","author":"Valachis A","year":"2013","unstructured":"Valachis A, Polyzos NP, Coleman RE, et al.. Adjuvant therapy with zoledronic acid in patients with breast cancer: a systematic review and meta-analysis. Oncologist. 2013, 18:353-61. 10.1634\/theoncologist.2012-0261","journal-title":"Oncologist"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbo.2015.08.001","article-title":"Dosing of zoledronic acid with its anti-tumor effects in breast cancer","volume":"4","author":"Zhao X","year":"2015","unstructured":"Zhao X, Hu X. Dosing of zoledronic acid with its anti-tumor effects in breast cancer. J Bone Oncol. 2015, 4:98-101. 10.1016\/j.jbo.2015.08.001","journal-title":"J Bone Oncol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2004-0952","article-title":"Severely suppressed bone turnover: a potential complication of alendronate therapy","volume":"90","author":"Odvina CV","year":"2005","unstructured":"Odvina CV, Zerwekh JE, Rao DS, Maalouf N, Gottschalk FA, Pak CY. Severely suppressed bone turnover: a potential complication of alendronate therapy. J Clin Endocrinol Metab. 2005, 90:1294-301. 10.1210\/jc.2004-0952","journal-title":"J Clin Endocrinol Metab"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1097\/RHU.0b013e3181cf3e3d","article-title":"Atypical insufficiency fracture of the tibia associated with long-term bisphosphonate therapy","volume":"16","author":"Breglia MD","year":"2010","unstructured":"Breglia MD, Carter JD. Atypical insufficiency fracture of the tibia associated with long-term bisphosphonate therapy. J Clin Rheumatol. 2010, 16:76-8. 10.1097\/RHU.0b013e3181cf3e3d","journal-title":"J Clin Rheumatol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s00774-007-0771-y","article-title":"Pelvic insufficiency fracture associated with severe suppression of bone turnover by alendronate therapy","volume":"25","author":"Imai K","year":"2007","unstructured":"Imai K, Yamamoto S, Anamizu Y, Horiuchi T. Pelvic insufficiency fracture associated with severe suppression of bone turnover by alendronate therapy. J Bone Miner Metab. 2007, 25:333-6. 10.1007\/s00774-007-0771-y","journal-title":"J Bone Miner Metab"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-012-2118-3","article-title":"Bilateral ulna fractures associated with bisphosphonate therapy","volume":"24","author":"Ang BF","year":"2013","unstructured":"Ang BF, Koh JS, Ng AC, Howe TS. Bilateral ulna fractures associated with bisphosphonate therapy. Osteoporos Int. 2013, 24:1523-5. 10.1007\/s00198-012-2118-3","journal-title":"Osteoporos Int"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3109\/17453674.2011.636676","article-title":"Atypical fracture of the ulna associated with alendronate use","volume":"82","author":"Bj\u00f8rgul K","year":"2011","unstructured":"Bj\u00f8rgul K, Reigstad A. Atypical fracture of the ulna associated with alendronate use. Acta Orthop. 2011, 82:761-3. 10.3109\/17453674.2011.636676","journal-title":"Acta Orthop"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhsa.2021.02.012","article-title":"Intractable fractures of the bilateral proximal ulnae after 8 years of zoledronate treatment for breast cancer bone metastasis","volume":"47","author":"Ohta S","year":"2022","unstructured":"Ohta S, Ikeguchi R, Noguchi T, Kaizawa Y, Matsuda S. Intractable fractures of the bilateral proximal ulnae after 8 years of zoledronate treatment for breast cancer bone metastasis. J Hand Surg Am. 2022, 47:393.e1-7. 10.1016\/j.jhsa.2021.02.012","journal-title":"J Hand Surg Am"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.798653","article-title":"Case report: prophylactic plate fixation for incomplete atypical ulnar fractures resulting from the use of denosumab for bone metastases","volume":"12","author":"Murai A","year":"2022","unstructured":"Murai A, Tada K, Nakajima T, Akahane M, Matsuta M, Nakamura Y, Tsuchiya H. Case report: prophylactic plate fixation for incomplete atypical ulnar fractures resulting from the use of denosumab for bone metastases. Front Endocrinol (Lausanne). 2022, 12:798653. 10.3389\/fendo.2021.798653","journal-title":"Front Endocrinol (Lausanne)"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/282133-multiple-stress-fractures-in-a-young-cancer-patient-on-long-term-zoledronic-acid-a-case-report-and-review-of-literature","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,23]],"date-time":"2024-09-23T14:40:21Z","timestamp":1727102421000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/282133-multiple-stress-fractures-in-a-young-cancer-patient-on-long-term-zoledronic-acid-a-case-report-and-review-of-literature"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,23]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.69999","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9,23]]}}}